DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Oncogene 2003 Jan;22(3):445-50

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

The human DLC-1 (deleted in liver cancer 1) gene was cloned from a primary human hepatocellular carcinoma (HCC) and mapped to the chromosome 8p21-22 region frequently deleted in common human cancers and suspected to harbor tumor suppressor genes. DLC-1 was found to be deleted or downregulated in a significant number of HCCs. We expanded our investigations to other cancers with recurrent deletions of 8p22, and in this study examined alterations of DLC-1 in primary human breast tumors, human breast, colon, and prostate tumor cell lines. Genomic deletion of DLC-1 was observed in 40% of primary breast tumors, whereas reduced or undetectable levels of DLC-1 mRNA were seen in 70% of breast, 70% of colon, and 50% of prostate tumor cell lines To see whether DLC-1 expression affects cell growth and tumorigenicity, two breast carcinoma cell lines lacking the expression of endogenous gene were transfected with the DLC-1 cDNA. In both cell lines, DLC-1 transfection caused significant growth inhibition and reduction of colony formation. Furthermore, introduction of the DLC-1 cDNA abolished the in vivo tumorigenicity in nude mice, suggesting that the DLC-1 gene plays a role in breast cancer by acting as a bona fide tumor suppressor gene.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206064DOI Listing
January 2003
38 Reads
50 Citations
8.460 Impact Factor

Publication Analysis

Top Keywords

cell lines
16
human breast
12
dlc-1
11
dlc-1 deleted
8
vivo tumorigenicity
8
cell growth
8
tumor suppressor
8
breast tumors
8
prostate tumor
8
tumor cell
8
lines dlc-1
8
primary human
8
dlc-1 cdna
8
dlc-1 gene
8
breast cancer
8
breast
7
human
6
cell
6
dlc-1 primary
4
breast colon
4

References

(Supplied by CrossRef)

Similar Publications